TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
Pharmaq Fishteq AS
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
53,245
|
51,674
|
50,529 |
Financial expenses |
1,693
|
1,370
|
1,535 |
Earnings before taxes |
8,626
|
-28,595
|
-3,580 |
Total assets |
36,317
|
72,218
|
73,327 |
Current assets |
22,001
|
53,647
|
29,863 |
Current liabilities |
18,178
|
59,638
|
59,594 |
Equity capital |
18,137
|
12,288
|
13,132 |
- share capital |
84
|
90
|
87 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
49.9%
|
17.0%
|
17.9% |
Turnover per employee | |||
Profit as a percentage of turnover |
16.2%
|
-55.3%
|
-7.1% |
Return on assets (ROA) |
28.4%
|
-37.7%
|
-2.8% |
Current ratio |
121.0%
|
90.0%
|
50.1% |
Return on equity (ROE) |
47.6%
|
-232.7%
|
-27.3% |
Change turnover |
4,995
|
-421
|
5,527 |
Change turnover % |
10%
|
-1%
|
12% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.